CPLX1

CPLX1 (Complexin I) is a presynaptic SNARE-complex-binding protein that exerts dual control over neurotransmitter release: it clamps spontaneous vesicle fusion to prevent premature exocytosis and simultaneously facilitates rapid Ca²⁺-triggered synchronous release, with its loss reducing release probability, loosening Ca²⁺-channel–vesicle coupling, and promoting excessive asynchronous release (PMID:26019341, PMID:25740533). CPLX1 is prominently expressed in parvalbumin-positive (PV+) interneurons, where its transcription is driven by PGC-1α via NRF-1, and its depletion impairs synchronous GABAergic transmission, contributes to seizure dynamics, and disrupts long-term memory (PMID:25339750, PMID:25610371, PMID:34788174). Genetic ablation of CPLX1 in mice and rats produces severe early-onset ataxia, dystonia, social behavior deficits, reduced dendritic branching in motor neurons, gastrointestinal dysfunction, and compromised nigrostriatal dopaminergic signaling, while circuit-level overexpression in the medial prefrontal cortex enhances excitatory transmission and causes social deficits and repetitive behaviors rescuable by riluzole (PMID:16000319, PMID:31875236, PMID:41188235). Beyond neurons, CPLX1 regulates Ca²⁺-stimulated insulin secretion in pancreatic β-cells, where its expression is controlled by REST via a neuron-restrictive silencer element (PMID:15126625).

1. 2004 High

   Establishing that CPLX1 functions outside neurons — in pancreatic β-cells it controls Ca²⁺-stimulated insulin secretion, and its expression is transcriptionally repressed by REST via an NRSE, revealing tissue-specific regulation of this presynaptic protein.

   Evidence siRNA knockdown and overexpression in β-cell lines/primary islets with secretion assays; EMSA and reporter assays for REST–NRSE binding

   PMID:15126625

   Open questions at the time

   • Mechanism by which both overexpression and knockdown impair secretion is unclear
   • Whether CPLX1 interacts with the same SNARE partners in β-cells as in neurons not established
2. 2005 High

   Demonstrating that CPLX1 loss causes severe neurological phenotypes — Cplx1 KO mice develop early ataxia, dystonia, tremor, and motor coordination deficits without cerebellar degeneration, establishing CPLX1 as essential for motor circuit function in vivo.

   Evidence Cplx1 knockout mice assessed with comprehensive behavioral battery (rotarod, gait analysis, open field, swim test)

   PMID:16000319

   Open questions at the time

   • Synaptic mechanism underlying motor phenotypes not yet identified
   • Whether motor deficits reflect cerebellar, spinal, or distributed circuit dysfunction not resolved
3. 2006 High

   Defining the developmental onset of CPLX1 dependence — ataxia appears by postnatal day 7, indicating CPLX1 is required during the critical period of motor circuit maturation.

   Evidence Longitudinal developmental behavioral assessment in Cplx1 KO mice from P7 to P21

   PMID:17188502

   Open questions at the time

   • Whether early ataxia reflects a developmental versus maintenance role is unresolved
   • Cell types responsible for the early phenotype not identified
4. 2007 High

   Extending CPLX1's behavioral role beyond motor function — KO mice lack social novelty preference and normal aggression with intact olfaction, implicating CPLX1 in social circuit neurotransmission specifically.

   Evidence Cplx1 KO mice tested in social novelty preference, resident-intruder aggression, and olfactory discrimination assays

   PMID:17652102

   Open questions at the time

   • Neural circuits and transmitter systems mediating the social deficits not mapped
   • Whether social deficits are secondary to motor impairment not fully excluded
5. 2009 High

   Revealing CPLX1's synapse-level mechanism in an identified central synapse — at the endbulb of Held, CPLX1 loss reduces release probability and desynchronizes transmission while cochlear encoding remains normal, localizing the defect to central synaptic release.

   Evidence Patch-clamp electrophysiology, in vivo single-unit recordings, and auditory brainstem responses in Cplx1 KO mice

   PMID:19553439

   Open questions at the time

   • Whether reduced release probability reflects a priming, docking, or Ca²⁺-coupling defect not distinguished
   • Compensatory changes by other complexin paralogues not assessed
6. 2014 High

   Identifying a transcriptional pathway controlling CPLX1 in inhibitory interneurons — PGC-1α in PV+ neurons is required for CPLX1 expression, and its conditional loss phenocopies CPLX1 deficiency with asynchronous GABA release and memory impairment, linking mitochondrial transcriptional coactivation to presynaptic vesicle release control.

   Evidence PV-specific conditional PGC-1α knockout mice with qRT-PCR, electrophysiology (asynchronous GABA release), and behavioral memory tests

   PMID:25339750

   Open questions at the time

   • Whether PGC-1α acts on the CPLX1 promoter directly or via NRF-1 was established elsewhere but ChIP at native locus not shown
   • Contribution of other PGC-1α targets (e.g., SYT2) to the phenotype not dissected
7. 2015 High

   Resolving the dual clamp/facilitator mechanism at a mammalian central synapse — at the calyx of Held, CPLX1 deletion reduces evoked release probability partly through loosened Ca²⁺-channel–vesicle coupling and causes excessive asynchronous release, without altering vesicle pool size, quantal size, or Ca²⁺ influx, establishing CPLX1 as a fusion clamp and synchronous release facilitator simultaneously.

   Evidence Calyx of Held patch-clamp electrophysiology and electron microscopy in Cplx1 KO mice

   PMID:26019341

   Open questions at the time

   • Structural basis for how CPLX1 tightens Ca²⁺ channel–vesicle coupling not determined
   • Whether the dual function involves distinct CPLX1 domains at this synapse not tested
8. 2015 High

   Extending PGC-1α–CPLX1 regulation to cerebellar Purkinje cells — PGC-1α KO reduces CPLX1 in cerebellum and causes Purkinje cell loss and reduced spike rate, providing a mechanistic link to the ataxia phenotype of CPLX1 loss.

   Evidence PGC-1α global and PV-conditional KO mice, qRT-PCR, stereological Purkinje cell counts, in vivo electrophysiology

   PMID:25610371

   Open questions at the time

   • Whether Purkinje cell loss is due to CPLX1 reduction specifically or other PGC-1α targets remains untested
   • Whether CPLX1 restoration rescues the Purkinje cell phenotype not attempted
9. 2015 High

   miR-137, a schizophrenia-associated microRNA, directly targets CPLX1 mRNA and its downregulation impairs vesicle release, mossy fiber LTP, and hippocampal memory, establishing a post-transcriptional regulatory layer for CPLX1 with psychiatric relevance.

   Evidence miR-137 gain/loss of function in human iPSC neurons and in vivo mouse hippocampus, EM vesicle pool analysis, LTP recordings, behavioral tests

   PMID:26005852

   Open questions at the time

   • Relative contribution of CPLX1 versus NSF and SYT1 (co-targets) to miR-137 phenotype not separated
   • Whether endogenous miR-137 variation significantly modulates CPLX1 levels in human brain unknown
10. 2018 Medium

    CPLX1 participates in high-molecular-weight SNARE-containing heteromeric complexes in human cortex, and the CPLX1/CPLX2 ratio in these complexes correlates with cognitive function during aging independently of neuropathology, suggesting stoichiometric balance of complexin paralogues matters for circuit performance.

    Evidence Blue-native PAGE and reconstitution assays with recombinant SNARE proteins in postmortem human cortex from a longitudinal aging cohort

    PMID:29496544

    Open questions at the time

    • Causal relationship between CPLX1/CPLX2 ratio and cognitive decline not established
    • Functional significance of the 500-kDa species not tested in living systems
11. 2019 High

    Cross-species validation in rat confirmed CPLX1 necessity for motor function and revealed additional phenotypes — decreased dendritic branching in spinal motor neurons and abnormal gastrointestinal histomorphology, expanding CPLX1's role beyond synaptic transmission to neuronal morphology and visceral innervation.

    Evidence CRISPR/Cas9 Cplx1 KO rats with behavioral battery, Golgi staining of spinal motor neurons, GI histology

    PMID:31875236

    Open questions at the time

    • Whether dendritic branching defects are cell-autonomous or secondary to activity changes unknown
    • Mechanism of GI dysfunction (enteric neuron vs. smooth muscle) not determined
12. 2021 Medium

    CPLX1 in PV+ interneurons contributes to seizure dynamics — PV-specific PGC-1α deletion, which reduces CPLX1, slows ictogenesis and reduces preictal discharge intensity, indicating that synchronous PV+ neuron output controlled by CPLX1 can paradoxically promote seizure initiation.

    Evidence PV-specific PGC-1α conditional KO, 0-Mg²⁺ ictogenic brain slice model, multi-electrode array recordings

    PMID:34788174

    Open questions at the time

    • CPLX1's role is inferred through PGC-1α manipulation rather than direct CPLX1 perturbation
    • Whether CPLX1 restoration in PV+ neurons is sufficient to re-accelerate ictogenesis untested
13. 2024 High

    Evolutionary specialization of CPLX1 expression in PV+ neurons supports ultrasound neurotransmission — echolocating microbats selectively upregulate CPLX1 in PV+ auditory neurons, and cell-type-specific perturbation of Cplx1 in mouse PV+ neurons impairs ultrasound perception, directly linking CPLX1 to temporal precision of sensory processing.

    Evidence Cross-species single-nucleus RNA-seq, AAV-mediated Cplx1 perturbation in mouse PV+ neurons, ultrasound perception behavioral assays

    PMID:38834904

    Open questions at the time

    • Specific synaptic parameters altered by Cplx1 perturbation in auditory PV+ neurons not measured
    • Whether CPLX1 upregulation is necessary and sufficient for echolocation ability untested
14. 2025 High

    Circuit-level overexpression of CPLX1 can be pathogenic — LINC02449-G-driven upregulation of CPLX1 in mPFC enhances excitatory transmission in mPFC-NAc projections and causes social deficits and repetitive behaviors, which are rescued by riluzole normalization of Cplx1, demonstrating that bidirectional CPLX1 dysregulation disrupts circuit function.

    Evidence AAV-mediated mPFC overexpression in mice, whole-cell patch-clamp (mEPSC in NAc), behavioral assays, riluzole pharmacological rescue

    PMID:41188235 PMID:41863379

    Open questions at the time

    • Whether riluzole acts specifically through CPLX1 or has additional targets in this circuit not resolved
    • LINC02449 mechanism of CPLX1 upregulation not fully characterized

• Key unresolved questions include: the structural basis for CPLX1's dual clamp/facilitator function at native SNARE complexes; whether CPLX1's role in Ca²⁺-channel–vesicle coupling involves direct physical interaction with Ca²⁺ channels; and whether CPLX1 dysregulation is a causal driver (rather than correlate) of cognitive decline in aging and psychiatric disease.
• No high-resolution structure of CPLX1 bound to the full SNARE complex at a mammalian synapse
• Causal relationship between CPLX1 stoichiometry in SNARE complexes and human cognitive phenotypes not demonstrated
• Cell-autonomous versus circuit-level contributions to motor and social phenotypes not dissected